Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 10, 2006

View Archived Issues

In vivo analysis of beta-lactamase inhibitor NXL-104

Database lock on SIMPADICO trial of Celacade

Crucell licenses STAR technology to Xoma for research

Takeda transfers BASF Takeda Vitamin shares to BASF Japan

Nippon Shinyaku grants Innovive license to NS-187 for CML

TMC-114/ritonavir POWER 2 clinical data and antiviral enhancement with Fuzeon

Preclinical profile of aminocandin presented at ICAAC

pSivida signs new evaluation agreements for new subsidiary

EpiCept completes merger with Maxim Pharmaceuticals

Phase I study to evaluate eniluracil plus 5-FU

AVI BioPharma gets allocation from 2006 defense appropriations act

ZIO-101 to begin phase I/II study in advanced melanoma

Treatment completed in pivotal TRIUMPH study of eculizumab in PNH

Xencor and Roche extend research collaboration

Gabapentin GR shows sustained pain relief without sedation

Study confirms effectiveness of synDNA vaccines in producing immunologic activity

iDESTRIN relieves signs and symptoms of dry eye syndrome in postmenopausal women

Vicuron discloses data on novel azetidine lincosamides

KCP-256: A novel glucose concentration-dependent potentiator of insulin secretion

HPW-RX2 shown to inhibit thrombin and thromboxane formation

Fast track designation for Valortim for anthrax

New approaches for HIV infection treatment disclosed in recent patent literature

New gastric acid antisecretory agents emerge from Altana R&D

Clinical data on brecanavir for HIV infection reported

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...